Outcomes in Schizophrenia Systematic Reviews

Similar documents
Long-term associations between use of antipsychotic medication and brain structural changes in schizophrenia

Systematic reviews and meta-analyses

Duration of untreated psychosis as predictor of long-term outcome in schizophrenia: systematic review and meta-analysis {

Occupational Therapy for First Episode Psychosis

Self-labelling and stigma as predictors of attitudes towards help-seeking among people at risk of psychosis: 1 year follow-up

POT WEED CHRONIC GREEN KUSH BUD HERB

Prognosis of schizophrenia spectrum disorder may not be predetermined during early

Results. NeuRA Family relationships May 2017

Information about the Critically Appraised Topic (CAT) Series

6th International Conference on Early Psychosis

XXIV Paulo International Medical Symposium Schizophrenia - Epidemiology and Biology

ACTA SYSTEMATIC SEARCH AND EVALUATION OF PUBLISHED SCIENTIFIC RESEARCH IMPLICATIONS FOR SCHIZOPHRENIA RESEARCH UNIVERSITATIS OULUENSIS D 1067

Results. NeuRA Worldwide incidence April 2016

Handout for the Neuroscience Education Institute (NEI) online activity: First-Episode Schizophrenia: Setting the Stage for Successful Outcomes

NeuRA Schizophrenia diagnosis May 2017

Sukanta Saha, 1 James Scott, 1,2,3,4 Daniel Varghese, 5 John McGrath 1,4,6

Schizophrenia: Early Intervention

Impact of antipsychotics on long-term course of psychotic illness. Donald Goff, MD Nathan Kline Institute NYU School of Medicine

Separable developmental trajectories in schizophrenia from womb to grave: results from the Northern Finland 1966 Birth Cohort.

BGS Falls Severe mental illness, poor bone health and falls: The potential role for physical activity

Method. NeuRA Negative symptoms April 2016

The impact of antipsychotic side effects on attitudes toward medication in patients with schizophrenia: A systematic review

Early Psychosis Services: Philadelphia PEACE Program

Early identification of neurobiological markers of remission. Michael Bodnar, PhD Ashok K. Malla, MD Martin Lepage, PhD

Research Article Predicting Depression with Psychopathology and Temperament Traits: The Northern Finland 1966 Birth Cohort

Suicides In Schizophrenia And Paranoid Psychoses (Acta Psychiatrica Scandinavica) By Matti Virkkunen

Beyond clozapine: a review of the literature on clozapine resistance

Results. NeuRA Motor dysfunction April 2016

November 2014 MRC2.CORP.X.00004

NeuRA Schizophrenia diagnosis June 2017

NeuRA Decision making April 2016

Lifetime use of psychiatric medications and cognition at 43 years of age in schizophrenia in the Northern Finland

Association between Global Assessment of Functioning scores and indicators of functioning, severity, and prognosis in first-time schizophrenia

Role of social media and the Internet in pathways to care for adolescents and young adults with psychotic disorders and non-psychotic mood disorders

Urbanization and the Determinants of Health: The Cities Changing Diabetes Programme

Schizoaffective Disorder

METHODS RESULTS. Supported by funding from Ortho-McNeil Janssen Scientific Affairs, LLC

King s Research Portal

Brief Report Duration of untreated psychosis and acute remission of negative symptoms in a South American first-episode psychosis cohort

The British Approach to Understanding and Treating Psychosis

Schizophrenia: New Concepts for Therapeutic Discovery

The outlook for schizophrenia is better than we think but is being sabotaged by Assembly-line Psychiatry

What if... there was nothing to recover?

Results. NeuRA Forensic settings April 2016

Individualising antipsychotic treatment for patients with schizophrenia John Donoghue Liverpool

Treatment of Schizophrenia

Linking the Developmental and Degenerative Theories of Schizophrenia: Association Between Infant Development and Adult Cognitive Decline

Results. NeuRA Treatments for dual diagnosis August 2016

Association between family history of psychiatric disorders and long-term outcome in

Effectiveness of early intervention in psychosis Eóin Killackey a,b and Alison R. Yung a,c

ACTA FAMILY HISTORY OF MENTAL DISORDERS AND LONG-TERM OUTCOME IN SCHIZOPHRENIA UNIVERSITATIS OULUENSIS D Juha Käkelä MEDICA OULU 2018

Effect of Instructional Module on Drug Adherence in Terms of Attitude among Patients with Schizophrenia

Obiettivo del trattamento della schizofrenia: RECOVERY FUNZIONALE

NeuRA Obsessive-compulsive disorders October 2017

W. De La Haye, M.D., M.P.H., D.M. Department of Community Health & Psychiatry, The University of the West Indies, Mona Campus, JAMAICA

C U R R I C U L U M V I T A E

University of Dundee DOI: / Publication date: Document Version Peer reviewed version

NeuRA Schizophrenia diagnosis October 2017

The Long-term Prognosis of Delirium

Cannabis for Medical Use: Body and Mind

Improving outcomes of first-episode psychosis: an overview

Predictors of schizophrenia a review

Applied Psychology Subject Guide

VALIDATION IN PROCESS

Does Long-Term Treatment of Schizophrenia With Antipsychotic Medications Facilitate Recovery?

Office Practice Coding Assistance - Overview

Abstract: "Evidence-Based Psychotherapy for Schizophrenia: Past, Present, and Future (Intermediate)

Hocus Pocus: How the National Institute of Mental Health Made Two Million People with Schizophrenia Disappear

A Systematic Review of the Efficacy and Clinical Effectiveness of Group Analysis and Analytic/Dynamic Group Psychotherapy

Religious Beliefs and Their Relevance for Adherence to Treatment in Mental Illness: A Review

Is Depression management getting you down? G. Michael Allan Director Programs and Practice Support, CFPC Professor, Family Med, U of A

Psychosocial intervention to optimal treatment to patients with schizophrenia: neurocognitive perspectives

OUR TEAM OUR SPECIALIZED PROGRAMS

Is Depression management getting you down? G. Michael Allan Director Programs and Practice Support, CFPC Professor, Family Med, U of A

Treatment Outcomes from the TDC: A Look at Smoking Cessation Among Patients with Co- Occurring Disorders

Accurate Diagnosis of Primary Psychotic Disorders

EARLY ONSET SCHIZOPHRENIA

Early Intervention Teams services for early psychosis

Supplementary Online Content

The Paranoid Patient: Perils and Pitfalls

Early psychosis intervention

The Global Research Framework of Cities Changing Diabetes. Prof. David Napier Global Academic Lead Cities Changing Diabetes

Responding to the Challenge of Treatment of Individuals with Co-occurring Substance Abuse and Psychotic Disorders: A Focus on Youth and Young Adults

LUP. Lund University Publications Institutional Repository of Lund University

Review Article The promise of early intervention

NeuRA Sleep disturbance April 2016

DEFINITION OF TERMS BACKGROUND. APNA 27th Annual Conference Session 2023: October 10, Boardman 1

Supplementary Online Content

A Systematic Review of the Effect of Early Interventions for Psychosis on the Usage of Inpatient Services

Supplementary appendix

SELECTED EPIDEMIOLOGICAL ASPECTS OF SCHIZOPHRENIA: A CROSS SECTIONAL STUDY AT TERTIARY CARE HOSPITAL IN MAHARASHTRA

Early intervention in psychosis: another triumph of hope over experience?

Gender Difference and PANSS Score of Paranoid Schizophrenia Using Risperidone

Does Family Structure Play a Role in Depression in Adolescents Admitted to Psychiatric Inpatient Care?

Mental Health Current Articles Bulletin - April 2018

Management of physical health conditions in adults with severe mental disorders

Trajectories of Symptom Dimensions in Short- Term Response to Antipsychotic Treatment in Patients with a First Episode of Non-Affective Psychosis

Received 11 August 2015; Accepted 23 February 2016; First published online 28 March Introduction

Fidelity and Outcomes in Community Care

Transcription:

Outcomes in Schizophrenia Systematic Reviews Jouko Miettunen Professor of Clinical Epidemiology Center for Life Course Epidemiology and Systems Medicine, University of Oulu, Finland This project is co-funded by the EC under H2020 research and innovation

AIMS The aim is to present recent systematic reviews related to long-term outcome of schizophrenia. Included reviews focus different aspects of schizophrenia Proportion of recovery Duration of untreated psychosis (DUP) as a predictor of outcome Family history of psychosis as a predictor of functional outcome 2

General methods of included systematic reviews several electronic databases Scopus, PubMed, Science Direct, ISI Web of Knowledge, PsycINFO (Ovid), CINAHL (EBSCO) and Academic Search Premier (EBSCO) and manual literature search Included articles were required to meet following criteria: at least 80% of the participants were individuals with a schizophreniaspectrum diagnosis follow-up time was at least 2 years since onset of illness majority of the subjects were older than 16 years at the onset of psychotic symptoms Clinical trials were excluded 3

Recovery criteria: improvements in both clinical and social domains and evidence that improvement in at least one of these two domains had persisted for at least two years 4

Recovery in schizophrenia In 50 studies, the median proportion of recovery was 13.5% Mean 16.4%, range 0-58% Studies from sites in countries with poorer economic status had higher recovery proportions. 5

Recovery in subpopulations 6

Gender differences in recovery 7

Recovery - Conclusion Based on the best available data, approximately one in seven individuals with schizophrenia met our criteria for recovery. Large heterogeneity in results and in methods. Despite major changes in treatment options in recent decades, the proportion of recovered cases has not increased. This project is co-funded by the EC under H2020 research and innovation 8

Duration of untreated psychosis and outcome 9

Duration of untreated psychosis and outcome 10

DUP - Conclusion Longer duration of untreated psychosis associated with poorer outcomes Average effect sizes were quite small Results indicate that early intervention may have subtle positive effects on outcome of schizophrenia This project is co-funded by the EC under H2020 research and innovation 11

Family history of psychosis and outcome 12

Family history of psychosis and global outcome 13

Family history - Conclusion Based on the review the presence of family history of psychosis has a relatively small but statistically significant negative effect on the occupational and global (i.e. combined occupational, social and clinical) outcome. This was the first systematic review on effects of family history on social aspects of outcome in schizophrenia. A previous review (Esterberg et al. Schizophr Res 2010; 120:121-30) has found a small but significant negative effect of family history on negative symptoms but not on positive symptoms (no follow-up required). These results have clinical relevance, such as possibility to direct interventions to the patient group with increased risk of poorer outcome. 14

Other potential outcome predictors Substance use Approximately 25% of schizophrenia patients have a cannabis use disorder and 20% have a alcohol use disorder Koskinen et al. Acta Psychiatr Scand 2009; 120:85-96 Koskinen et al. Schizophr Bull 2010; 36:1115-30 Those who continue to abuse substances have worse outcome Gupta et al. Aust N Z J Psychiatry. 2013; 47:524-37 Large et al. Aust N Z J Psychiatry 2014; 48:418-32 Medications and medication adherence Leucht et al. Lancet 2012; 379: 2063-71 Emsley et al. BMC Psychiatry 2013; 13:50 Zipursky et al. J Clin Psychiatrry 2014; 75 (Suppl. 2):20-24 Onset age? Marital status? Adverse life events? 15

Main references Jääskeläinen E, Juola P, Hirvonen N, McGrath JJ, Saha S, Isohanni M, Veijola J, Miettunen J. A systematic review and meta-analysis of recovery in schizophrenia. Schizophr Bull 2013; 39:1296-1306. Käkelä J, Panula J, Oinas E, Hirvonen N, Jääskeläinen E, Miettunen J. Family history of psychosis and social, occupational and global outcome in schizophrenia: a meta-analysis. Acta Psychiatr Scand 2014; 130:269-78. Penttilä M, Jääskeläinen E, Hirvonen N, Isohanni M, Miettunen J. Duration of untreated psychosis as predictor of long-term outcome in schizophrenia. A systematic review and metaanalysis. Br J Psychiatry 2014; 205:88-94. 16

Jouko Miettunen, prof.; Erika Jääskeläinen, adjunct prof. Center for Life Course Epidemiology and Systems Medicine, University of Oulu, Oulu, Finland & Medical Research Center Oulu, Oulu University Hospital and University of Oulu, Oulu, Finland Matti Penttilä, MScD; Pauliina Juola, MScD; Juha Käkelä, BMed; Matti Isohanni, prof. Center for Clinical Neurosciences, University of Oulu, Oulu, Finland & Department of Psychiatry, Oulu University Hospital, Oulu, Finland Noora Hirvonen, MA Information Studies, Faculty of Humanities, University of Oulu, Oulu, Finland John J McGrath, prof; Sukanta Saha, PhD University of Queensland, St Lucia, Australia This project is co-funded by the EC under H2020 research and innovation jouko.miettunen@oulu.fi / www.joukomiettunen.net 17